HNGE
Hinge Health, Inc.
$55.25
+0.13
(+0.24%)
Mkt Cap
4.28B
Volume
1,134,024
52W Range
30.08-62.18
Sector
Healthcare
Beta
1.65
EPS (TTM)
-6.58
P/E Ratio
-6.96
Revenue (TTM)
646.34M
Rev Growth (5Y)
+41.7%
EPS Growth (5Y)
N/A
Company Description
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 587.86M | 390.40M | 292.73M |
| Net Income | (528.26M) | (11.93M) | (108.14M) |
| EPS | -5.36 | -0.15 | -1.39 |
| Free Cash Flow | 170.73M | 45.23M | (68.52M) |
| FCF / Share | 2.16 | 0.58 | -0.88 |
| Operating CF | 171.44M | 49.00M | (63.91M) |
| Total Assets | 744.76M | 673.26M | 622.53M |
| Total Debt | 8.04M | 11.07M | 15.73M |
| Cash & Equiv | 208.00M | 300.79M | 234.95M |
| Book Value | 378.54M | 416.70M | 427.28M |
| Return on Equity | -1.40 | -0.03 | -0.25 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 182.31M | 170.73M | 154.21M | 139.10M | 123.83M | 117.26M | 100.61M | 89.83M | 82.71M | 81.52M | 81.35M | 69.84M |
| Net Income | 35.13M | 32.09M | (1.84M) | (679.83M) | 121.31M | 27.12M | 341,000 | (12.93M) | (26.46M) | (24.11M) | (16.77M) | (31.84M) |
| EPS | 0.43 | 0.39 | -0.02 | -7.38 | 1.55 | 0.35 | 0.00 | -0.19 | -0.34 | -0.31 | -0.21 | -0.41 |
| Free Cash Flow | 43.00M | 63.49M | 81.28M | 18.40M | 4.17M | 37.31M | 28.08M | 13.99M | (33.61M) | N/A | N/A | N/A |
| FCF / Share | 0.55 | 0.80 | 1.03 | 0.24 | 0.05 | 0.48 | 0.36 | 0.20 | -0.43 | N/A | N/A | N/A |
| Operating CF | 43.08M | 63.90M | 82.40M | 20.23M | 4.92M | 38.34M | 28.40M | 14.92M | (32.66M) | N/A | N/A | N/A |
| Total Assets | 728.77M | 744.76M | 769.80M | 693.65M | 712.53M | 675.48M | N/A | N/A | 0 | N/A | N/A | N/A |
| Total Debt | 6.97M | 8.04M | 9.03M | 9.97M | 10.13M | 18.33M | N/A | N/A | 0 | N/A | N/A | N/A |
| Cash & Equiv | 188.11M | 208.00M | 261.34M | 237.17M | 288.48M | 302.59M | N/A | N/A | 0 | N/A | N/A | N/A |
| Book Value | 311.56M | 378.54M | 407.87M | 373.65M | 438.82M | 416.70M | N/A | N/A | 427.28M | N/A | N/A | N/A |
| Return on Equity | 0.11 | 0.08 | -0.00 | -1.82 | 0.28 | 0.07 | N/A | N/A | -0.06 | N/A | N/A | N/A |
HNGE News
Does Hinge Health Inc. (HNGE) Have the Potential to Rally 25.14% as Wall Street Analysts Expect?
Surging Earnings Estimates Signal Upside for Hinge Health Inc. (HNGE) Stock
Hinge Health Q1 Earnings Call Highlights
HNGE Stock Up on Q1 Earnings & Revenue Beat, 2026 Outlook Improved
Hinge Health, Inc. (HNGE) Q1 2026 Earnings Call Transcript
Hinge Health reports record first quarter 2026 financial results
Hinge Health launches comprehensive Migraine Care Program
Analyzing Hinge Health (NYSE:HNGE) and 10x Genomics (NASDAQ:TXG)
Director Sells 50,000 Shares of Digital Health Platform Stock for $1.9 Million, According to Recent SEC Filing
Hinge Health (NYSE:HNGE) Chairman Gabriel M.I. Mecklenburg Sells 50,000 Shares of Stock